SEC Form 4/A · accession 0001387131-16-005609
Adamis Pharmaceuticals Corp · ADMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David J. Marguglio
Officer — SR VP OF CORPORATE DEVELOPMENT · Director
Period of report
May 9, 2016
Accepted (ET)
May 18, 2016 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000887247
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2016 | S | 6,000 | $10.00 | D | 106,227 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted in September 2015.
Remarks
This Form 4/A is filed to correct an inadvertent error of the reporting person's Form 4 filed May 11, 2016. The inadvertent error on Table I, Column 4 incorrectly reported the amount of securities sold on May 9, 2016.